Literature DB >> 9332915

Disease recurrence after resection for stage I lung cancer.

K al-Kattan1, E Sepsas, S W Fountain, E R Townsend.   

Abstract

OBJECTIVE: To asses the incidence of local recurrence and distant metastases after complete resection for stage I lung cancer in order to predict the predominant prognostic factors.
METHODS: We retrospectively reviewed 123 patients with stage I lung cancer who underwent curative resection over a 2-year period between January 1987 and December 1988. There were 83 male and 40 female patients with a mean age of 64.8 +/- 12 years (range between 39 and 82 years). Multivariate analysis of prognostic factors for long term survival was undertaken.
RESULTS: T1N0 lesions were found in 34 patients and T2N0 in 89. The histological diagnosis was Squamous carcinoma in 75, Adenocarcinoma in 38, large cell carcinoma in 6 and small cell carcinoma in 4 patients. Pneumonectomy was performed in 27 patients (5 T1 and 22 T2) while 96 required lobectomy (29 T1 and 67 T2). At 5 years 50 patients died. This was due to local recurrence in 12, distant metastasis in 24, second primary in 1, unrelated disease in 3, while the cause was unknown in 10 patients. At 5 years, 10 patients were alive with evidence of recurrence. The mean interval for local recurrence was 19.8 months and for distant metastasis was 18 months. The overall 5 year survival was 67% +/- 4 for T1 and 56% +/- 5 for T2 lesions (NS). The rate of recurrence was significantly less for T1 lesions (P = 0.02). Survival was significantly less for patients requiring pneumonectomy rather than lobectomy (P = 0.01) whether for T1 or T2.
CONCLUSION: In stage I lung cancer T2 lesions requiring pneumonectomy for complete resection had a worse prognosis and higher incidence of local recurrence.

Entities:  

Mesh:

Year:  1997        PMID: 9332915     DOI: 10.1016/s1010-7940(97)00198-x

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  39 in total

1.  Very long-term outcomes of video-assisted thoracoscopic surgery for lung cancer.

Authors:  Shigeki Sawada; Eisaku Komori; Motohiro Yamashita
Journal:  Surg Endosc       Date:  2008-07-12       Impact factor: 4.584

2.  Selection for adjuvant chemotherapy in completely resected stage I non-small cell lung cancer: external validation of a Chinese prognostic risk model.

Authors:  Ulas Kumbasar; Hilgardt Raubenheimer; May Al Sahaf; Nizar Asadi; Maria Elena Cufari; Chiara Proli; Periklis Perikleous; Zakiyah Niwaz; Emma Beddow; Vladimir Anikin; Niall McGonigle; Simon Jordan; George Ladas; Michael Dusmet; Eric Lim
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

3.  Prognostic value of radiomic analysis of iodine overlay maps from dual-energy computed tomography in patients with resectable lung cancer.

Authors:  Jooae Choe; Sang Min Lee; Kyung-Hyun Do; Jung Bok Lee; Sang Min Lee; June-Goo Lee; Joon Beom Seo
Journal:  Eur Radiol       Date:  2018-07-27       Impact factor: 5.315

4.  Editorial on "Long-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is 'cured' from postoperative recurrence?"

Authors:  Joachim Pfannschmidt
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

5.  Timing, Sites, and Correlates of Lung Cancer Recurrence.

Authors:  Chelsea M Karacz; Jingsheng Yan; Hong Zhu; David E Gerber
Journal:  Clin Lung Cancer       Date:  2019-12-20       Impact factor: 4.785

6.  Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.

Authors:  Shinsuke Saisho; Koichiro Yasuda; Ai Maeda; Takuro Yukawa; Riki Okita; Yuji Hirami; Katsuhiko Shimizu; Masao Nakata
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-09

7.  Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.

Authors:  Lucas W Thornblade; Michael S Mulligan; Katherine Odem-Davis; Billanna Hwang; Rachel L Waworuntu; Erika M Wolff; Larry Kessler; Douglas E Wood; Farhood Farjah
Journal:  Ann Thorac Surg       Date:  2018-07-19       Impact factor: 4.330

Review 8.  Survivin as a novel target protein for reducing the proliferation of cancer cells.

Authors:  Dongyu Li; Chenghao Hu; Huibin Li
Journal:  Biomed Rep       Date:  2018-03-13

9.  Isolated brain metastasis as a late recurrence of completely resected non-small cell lung cancer.

Authors:  Lixia Ju; Mingquan Han
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

10.  18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.

Authors:  Hiroaki Toba; Shoji Sakiyama; Hideki Otsuka; Yukikiyo Kawakami; Hiromitsu Takizawa; Koichiro Kenzaki; Kazuya Kondo; Akira Tangoku
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.